Insights into the treatment of human Prostate cancer: Bicalutamide, an Androgen receptor antagonist, increases the expression of tumor suppressor GRHL3 via down regulation of its target gene, 14/April/2014, 8.21 am

Insights into the treatment of human Prostate cancer: Bicalutamide, an Androgen receptor antagonist, increases the expression of tumor suppressor TIMP3 via down regulation of its target gene, 14/April/2014, 8.18 am
April 14, 2014
Insights into the treatment of human Prostate cancer: Bicalutamide, an Androgen receptor antagonist, increases the expression of tumor suppressor INK4a/p16 via down regulation of its target gene, 14/April/2014, 8.30 am
April 14, 2014
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, Insights into the treatment of human Prostate cancer: Bicalutamide, an Androgen receptor antagonist, increases the expression  of tumor suppressor GRHL3 via down regulation of its target gene, 14/April/2014, 8.21 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Comments are closed.